{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:13:01Z","timestamp":1773277981266,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ejso.2007.01.017","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T22:01:32Z","timestamp":1173391292000},"page":"535-540","source":"Crossref","is-referenced-by-count":11,"title":["Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: Why, how and when"],"prefix":"10.1016","volume":"33","author":[{"given":"D.","family":"Barbaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Boni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejso.2007.01.017_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/jc.86.4.1447","article-title":"Current approaches to primary therapy for papillary and follicular thyroid cancer","volume":"86","author":"Mazzaferri","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2007.01.017_bib2","first-page":"28S","article-title":"The evolving role of 131I for the treatment of differentiated thyroid cancer","volume":"46","author":"Robbins","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2007.01.017_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/thy.1997.7.265","article-title":"Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma","volume":"7","author":"Mazzaferri","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.ejso.2007.01.017_bib4","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/jc.83.12.4195","article-title":"The use of radioactive iodine in patients with papillary and follicular thyroid cancer","volume":"83","author":"Wartofsky","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2007.01.017_bib5","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","article-title":"A systemic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well differentiated thyroid cancer","volume":"89","author":"Sawka","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2007.01.017_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.1997.7.613","article-title":"Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy","volume":"7","author":"Dow","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.ejso.2007.01.017_bib7","article-title":"Setting New Standards in Thyroid Cancer Management","author":"Product Monograph","year":"2005","journal-title":"Genzyme"},{"issue":"9","key":"10.1016\/j.ejso.2007.01.017_bib8","first-page":"1549","article-title":"Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid stimulating hormone to treat metastatic differentiated thyroid cancer","volume":"45","author":"De Keizer","year":"2004","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.ejso.2007.01.017_bib9","first-page":"900","article-title":"Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH","volume":"46","author":"Lassmann","year":"2005","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.ejso.2007.01.017_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/thy.1999.9.451","article-title":"Pharmacology of bovine and human thyrotropin: an historical perspective","volume":"9","author":"Robbins","year":"1999","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.ejso.2007.01.017_bib11","doi-asserted-by":"crossref","DOI":"10.1517\/14656566.5.12.2503","article-title":"Clinical uses of recombinant human thyrotropin","volume":"5","author":"Gourgiotis","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.ejso.2007.01.017_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1210\/endo-128-1-341","article-title":"Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells","volume":"128","author":"Thotakura","year":"1991","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.ejso.2007.01.017_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.74.5.1135","article-title":"Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey","volume":"74","author":"Braverman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2007.01.017_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1210\/jc.78.1.188","article-title":"Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I\/II study)","volume":"78","author":"Meier","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2007.01.017_bib15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199709253371304","article-title":"Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma","volume":"337","author":"Ladenson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2007.01.017_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/acta.0.1200547","article-title":"The management of differentiated thyroid cancer in Europe in 1998","volume":"120","author":"Baldet","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.ejso.2007.01.017_bib17","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.84.11.3877","article-title":"A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer","volume":"84","author":"Haugen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejso.2007.01.017_bib18","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/en.133.4.1490","article-title":"Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity","volume":"133","author":"Szkudlinski","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejso.2007.01.017_bib19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/nbt0993-1014","article-title":"Recombinant human thyroid stimulating hormone: development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma","volume":"11","author":"Cole","year":"1993","journal-title":"Bio Technology"},{"key":"10.1016\/j.ejso.2007.01.017_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2265.2004.02025.x","article-title":"Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter","volume":"61","author":"Woodmansee","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.ejso.2007.01.017_bib21","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/jc.87.4.1490","article-title":"Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow up of differentiated thyroid cancer after thyroid ablation?","volume":"87","author":"Mazzaferri","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2007.01.017_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/eje.0.1500105","article-title":"Follow up of low risk patients with differentiated thyroid carcinoma: a European perspective","volume":"150","author":"Schlumberger","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejso.2007.01.017_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jc.86.2.619","article-title":"Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma","volume":"86","author":"Robbins","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejso.2007.01.017_bib24","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1089\/105072501753271707","article-title":"Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer","volume":"11","author":"Pellegriti","year":"2001","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.ejso.2007.01.017_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF03343758","article-title":"The use of recombinant human TSH in patient with metastatic follicular carcinoma and insufficient endogenous TSH production","volume":"23","author":"Luster","year":"2000","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.ejso.2007.01.017_bib26","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jc.85.10.3640","article-title":"Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma","volume":"85","author":"Luster","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejso.2007.01.017_bib27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4158\/EP.6.6.460","article-title":"Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature","volume":"6","author":"Robbins","year":"2000","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.ejso.2007.01.017_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1530\/eje.0.1440005","article-title":"Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH","volume":"144","author":"Lippi","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.ejso.2007.01.017_bib29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/105072501316973127","article-title":"Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin","volume":"11","author":"Robbins","year":"2001","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.ejso.2007.01.017_bib30","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1210\/jc.2001-011918","article-title":"Ablation of thyroid residues with 30 mCi 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal","volume":"87","author":"Pacini","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2007.01.017_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF03343960","article-title":"Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone","volume":"25","author":"Berg","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"10.1016\/j.ejso.2007.01.017_bib32","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1210\/jc.2003-030298","article-title":"Radioiodine treatment with 30Mci after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness of postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation","volume":"88","author":"Barbaro","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejso.2007.01.017_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/jc.2005-1651","article-title":"Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study","volume":"91","author":"Pacini","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejso.2007.01.017_bib34","first-page":"648","article-title":"Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal","volume":"47","author":"Hanscheid","year":"2006","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.ejso.2007.01.017_bib35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00006231-200608000-00005","article-title":"Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post\u00a0surgical thyroid remnants","volume":"27","author":"Barbaro","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2007.01.017_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-2265.2003.01735.x","article-title":"Effects of low iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma","volume":"58","author":"Pluijmen","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.ejso.2007.01.017_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00259-003-1251-9","article-title":"Effects of diuretics on iodine uptake in non-toxic goitre: comparison with low-iodine diet","volume":"30","author":"Kapucu","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ejso.2007.01.017_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1210\/jc.2003-031650","article-title":"Two cases of thyroid carcinoma that were not stimulated by recombinant human thyrotropin","volume":"89","author":"Driedger","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ejso.2007.01.017_bib39","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1445-5994.2006.01149.x","article-title":"Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy","volume":"36","author":"Lau","year":"2006","journal-title":"Intern Med J"},{"issue":"8","key":"10.1016\/j.ejso.2007.01.017_bib40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.rlu.0000227013.36421.ce","article-title":"A pragmatic protocol for I-131 rhTSH-stimulated ablation therapy in patients with renal failure","volume":"31","author":"Driedger","year":"2006","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.ejso.2007.01.017_bib41","first-page":"125","article-title":"Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma","volume":"66","author":"Pitoia","year":"2006","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"10.1016\/j.ejso.2007.01.017_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1677\/erc.1.00830","article-title":"rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review","volume":"12","author":"Luster","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2007.01.017_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/eje.1.02223","article-title":"Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective","volume":"155","author":"Mernagh","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ejso.2007.01.017_bib44","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00259-004-1502-4","article-title":"Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH?","volume":"31","author":"Pitoia","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798307000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798307000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T11:26:55Z","timestamp":1556191615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798307000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0748798307000327"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2007.01.017","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}